Clinical trial
Evaluation and Prediction of Relapse Risk After Glucocorticoid and Immunosuppressant Withdrawal in Patients With Stable IgG4 Related Disease: An Open-labeled Multi-centric Randomized Controlled Study From China
NCT04124861 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation and Prediction of Relapse Risk After Glucocorticoid and Immunosuppressant Withdrawal in Patients With Stable IgG4 Related Disease: An Open-labeled Multi-centric Randomized Controlled Study From China
- Lead sponsor
- Peking Union Medical College Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 23, 2020
- Completion date
- June 30, 2023
- Enrollment
- 138 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.